Oncode Accelerator

Oncode Accelerator is a public-private partnership that is funded by the Dutch National Growth Fund (Nationaal Groeifonds). Our program launched in 2023, when the National Growth Fund invested €325 million to support our ambitious plan. Our mission is bold: we aim to collaboratively optimize and accelerate the development of new cancer therapies for the benefit of patients of all ages. To accomplish this, we bring together top technology, bright minds, and non-dilutive co-funding so that great ideas can progress faster.To accelerate the development of safe, personalized and effective therapies, we place the patient at the center of the preclinical development pipelines.  We do this by fully utilizing the power of three innovation Platforms: well-defined Patient Cohorts, patient-derived Organoid models and Artificial Intelligence.  

We integrate expertise from our innovation Platforms into the drug development process to accelerate the development of four key types of therapies that benefit our society: Small Molecules, Biologics, Cell & Gene Therapy, and Therapeutic Vaccines. ​​These four types of therapies make up our Workstreams.